Smoking cessation and outcome after ischemic stroke or TIA
Katherine A. Epstein(Western University), Andreas Hetzel(University Medical Center Freiburg), Silvio E. Inzucchi(Yale University), Albrecht Günther(Friedrich Schiller University Jena), Otto W. Witte(University of Göttingen), J. David Spence(Institute for Atherosclerosis Research), Christopher Levi(John Hunter Hospital), Tissa Wijeratne(Sunshine Hospital), Grant Stotts, B. Griewing, Ariane Mackey(Hôpital de l'Enfant-Jésus), Robert Côté, Candice Delcourt(University of Leicester), Walter N. Kernan, Amy Brodtmann(The University of Melbourne), Peter Guarino(VA Connecticut Healthcare System), Ulf Bodechtel, John D. Archer, Ashfaq Shuaib(University of Alberta), Andrew M. Penn, Hassan Soda, Renate Weinhardt, Anett Stoll(Klinikum Altenburger Land), Mark Gorman, Léo Berger, Ulf Schminke(Universität Greifswald), Steve Verreault, Mark Parsons(UNSW Sydney), Neville Bayer, André Durocher, Carsten Hobohm(Merseburg University of Applied Sciences), Daniel Selchen, Lawrence H. Young(Yale University), Stephen C. Davis(University of Melbourne), Catherine M. Viscoli(Western University), Richard Chan, Christopher Bladin, Jeffrey Minuk, Anand Dixit(Western University), Margaret Sweet, Jörg Berrouschot(Klinikum Altenburger Land), Jean‐Martin Boulanger(Western University), Brett Gerstenhaber(Western University), Steven Ng, Karen L. Furie(Brown University)
Cited by 94
Related Papers
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
|New England Journal of Medicine|2015|11.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k